Humana Inc. (NYSE:HUM) Shares Sold by USS Investment Management Ltd

USS Investment Management Ltd reduced its position in Humana Inc. (NYSE:HUM - Free Report) by 9.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,056 shares of the insurance provider's stock after selling 2,061 shares during the period. USS Investment Management Ltd's holdings in Humana were worth $5,087,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in HUM. Dodge & Cox grew its stake in shares of Humana by 106.7% during the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after buying an additional 5,264,045 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Humana by 15.8% during the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock valued at $3,254,899,000 after buying an additional 1,751,857 shares during the last quarter. Norges Bank bought a new position in shares of Humana during the fourth quarter valued at approximately $416,202,000. Pzena Investment Management LLC grew its stake in shares of Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after buying an additional 1,103,132 shares during the last quarter. Finally, Boston Partners grew its stake in shares of Humana by 435.8% during the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock valued at $279,236,000 after buying an additional 893,637 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. Wall Street Zen raised Humana from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Morgan Stanley dropped their price objective on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 12th. Robert W. Baird increased their price objective on Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Oppenheimer increased their price objective on Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a research note on Thursday, May 1st. Finally, Barclays increased their price objective on Humana from $270.00 to $322.00 and gave the stock an "equal weight" rating in a research note on Friday, April 11th. Seventeen equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $286.81.

Humana Stock Performance

HUM stock traded up $3.47 during midday trading on Wednesday, reaching $230.08. The stock had a trading volume of 688,907 shares, compared to its average volume of 1,775,482. The stock has a market cap of $27.77 billion, a PE ratio of 23.12, a P/E/G ratio of 2.05 and a beta of 0.49. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a fifty day simple moving average of $259.52 and a two-hundred day simple moving average of $267.76. Humana Inc. has a 52-week low of $212.45 and a 52-week high of $406.46.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. The company had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. The firm's quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter last year, the business posted $7.23 EPS. As a group, equities research analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.54%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio is currently 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.